Search Results 291-300 of 11520 for VEO-IBD

  1. A Study to Evaluate Evacuation Mechanisms Using Advanced Brain Imaging - Mayo Clinic

    Active rectal inflammation, cancer; perianal sepsis; history of pelvic radiation in the past 3 years, rectal resection, or inflammatory bowel disease.* ...

  2. Arthur Beyder, M.D., Ph.D. - Doctors and Medical Staff - Mayo Clinic

    Areas of clinical expertise include: Motility Disorders; Irritable Bowel Syndrome; Gastrointestinal Mechanosensory Dysfunction. In addition to his clinical ...

  3. Reducing Intestinal Permeability with Hemp Hull WFI in IBS-Diarrhea With Evidence of Bile Acid Diarrhea - Mayo Clinic

    The purpose of this study is to demonstrate reduced intestinal permeability after 3 weeks of BB01 (20g of BB01, which reflects 15g of insoluble dietary fiber) ...

  4. John K. DiBaise, M.D. - Doctors and Medical Staff - Mayo Clinic

    DiBaise, M.D., is a board-certified gastroenterologist with expertise in GI motility and nutrition-related disorders. He is also a Professor of Medicine at Mayo ...

  5. An Expanded Access Study of Sofosbuvir Combined with Ribavirin and Either with or without Pegylated Interferon for Treating Aggressive Post-Transplant Hepatitis C - Mayo Clinic

    The purpose of this study, is to open expanded access at specific clinical sites at the request of an investigator for the treatment of individual subjects for ...

  6. A Study to Evaluate Budesonide in Patients with Immune Mediated Enteropathies - Mayo Clinic

    Oral budesonide for active Crohn's disease. Canadian Inflammatory Bowel Disease Study Group. Greenberg GR. G R; Feagan BG. B G; Martin F. F; Sutherland LR ...

  7. A Study of Budesonide Suspension in Adolescents and Adults with Eosinophilic Esophagitis Measuring Histologic Response and Decreased Dysphagia - Mayo Clinic

    ... colitis, or proctitis; inflammatory bowel disease; or celiac disease. Participant has other diseases causing or associated with EoE, including ...

  8. Pediatrics Clinical Trials - Medical Professionals

    albicans to dysbiotic microbial communities of mucosal tissues in pediatric populations. Prospective sampling across multiples tissue sites in a pediatric ...

  9. Management of recurrent Clostridioides difficile infection and use of fecal microbiota transplantation during the COVID-19 pandemic - Mayo Clinic

    Testing and COVID-19 status matching of both stool donors and fecal microbiota transplantation (FMT) recipients must occur to prevent transmitting COVID-19 ...

  10. Immunological Perturbation in Patients with Birt-Hogg-Dube Syndrome - Mayo Clinic

    About this study. The purpose of this study is to determine whether FLCN mutations affect immune cell homeostasis and function.